drug

zuranolone

Marketedupdated 2mo ago

by Sage Therapeutics Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 31, 2028

~2.3 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (15)

Aug 23, 2037compositionUS 11236121
Aug 23, 2037compositionUS 11236121
Aug 23, 2037compositionUS 11236121
Aug 23, 2037method-of-use (U-2552)US 11884696
Aug 23, 2037method-of-use (U-2552)US 11884696
Aug 23, 2037method-of-use (U-2552)US 11884696
Apr 17, 2034method-of-use (U-2552)US 10172871
Apr 17, 2034method-of-use (U-2552)US 10172871
Apr 17, 2034method-of-use (U-2552)US 10172871
Apr 17, 2034method-of-use (U-2552)US 10342810
Apr 17, 2034method-of-use (U-2552)US 10342810
Apr 17, 2034method-of-use (U-2552)US 10342810
Apr 17, 2034compositionUS 9512165
Apr 17, 2034compositionUS 9512165
Apr 17, 2034compositionUS 9512165

FDA exclusivities (3)

Oct 31, 2028NCENew Chemical Entity (5y)2.3y
Oct 31, 2028NCENew Chemical Entity (5y)2.3y
Oct 31, 2028NCENew Chemical Entity (5y)2.3y

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?